NY AG Fines Endo For Falsely Advertising Opioid Opana ER

By Dani Kass (March 3, 2016, 1:32 PM EST) -- New York's attorney general on Thursday announced he had imposed a $200,000 penalty on Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. for telling its sales representatives to hide and distort the addictive tendencies of the opioid painkiller Opana ER and falsely advertising that the pills are crush resistant....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as